Ramesh Kumar
Director/Board Member chez OCUGEN, INC.
Fortune : - $ au 31/03/2024
Profil
Ramesh Kumar was the founder of Onconova Therapeutics, Inc. (founded in 1998) where he served as the Chief Executive Officer & Director from 2018 to 2019.
He is currently working as an Independent Director at Ocugen, Inc. since 2019 and as a Director at Ocugen OpCo, Inc. since 2019.
Dr. Kumar has also held former positions as a Director at Nextran, a Scientist at Bristol Myers Squibb Co., the President-Genomics & Transgenics Division at Kimeragen, Inc., and as a Principal at Princeton University and the National Cancer Institute.
He holds a doctorate degree from the University of Illinois and undergraduate and graduate degrees from Panjab University Chandigarh.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OCUGEN INC
-.--% | 09/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Ramesh Kumar
| Sociétés | Poste | Début |
|---|---|---|
| OCUGEN, INC. | Director/Board Member | 27/09/2019 |
| Ocugen OpCo, Inc. | Director/Board Member | 01/06/2019 |
Anciens postes connus de Ramesh Kumar
| Sociétés | Poste | Fin |
|---|---|---|
| TRAWS PHARMA, INC. | Founder | 15/01/2019 |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | - |
Nextran
 Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The private company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Director/Board Member | - |
| Kimeragen, Inc. | Corporate Officer/Principal | - |
| Princeton University | Corporate Officer/Principal | - |
Formation de Ramesh Kumar
| University of Illinois | Doctorate Degree |
| Panjab University Chandigarh | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| TRAWS PHARMA, INC. | Health Technology |
| OCUGEN, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Kimeragen, Inc. | Commercial Services |
Nextran
Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The private company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Health Technology |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
| Ocugen OpCo, Inc. |
